EAST NORRITON, Pa., Jan. 2 /PRNewswire/ -- Tengion Inc., a clinical stage regenerative medicine company focused on the development of neo-organs and neo-vessels, announced today that Steven Nichtberger, M.D., president and chief executive officer of Tengion, is scheduled to present at the 26th Annual JP Morgan Healthcare Conference on Monday, January 7, 2008 at 11:00 a.m. PST. The conference will be held January 7 - 10 at The Westin St. Francis Hotel in San Francisco.
About Tengion
Tengion, a clinical stage biotechnology company, has pioneered the Autologous Organ Regeneration Platform(TM) that catalyzes the body’s innate ability to regenerate. Tengion’s neo-organs and neo-tissues in development, such as bladders and vessels, combine biocompatible materials and a patient’s own (autologous) cells to regenerate diseased and failing organs and tissues. Tengion’s product candidates have the potential to cure -- rather than treat -- organ and tissue failure, enabling people to lead healthier lives without donor transplants or the side effects of related therapies. For more information on the company and current clinical trials, visit Tengion online at: http://www.tengion.com.
CONTACT: Gary Sender of Tengion, Inc., +1-267-960-4802,
gary.sender@tengion.com
Web site: http://www.tengion.com/
